Education
About Us
Working with TipRanks
Follow Us
China NT Pharma Group Co., Ltd. (HK:1011)
:1011
Total Valuation
China NT Pharma Group Co., Ltd. has a market cap or net worth of HK$525.91M. The enterprise value is HK$780.19M.
Market CapHK$525.91M
Enterprise ValueHK$780.19M
Share Statistics
China NT Pharma Group Co., Ltd. has 674,246,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding674,246,030
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China NT Pharma Group Co., Ltd.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 56.99%.
Return on Equity (ROE)0.13
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)56.99%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee1.73M
Profits Per Employee-2.43M
Employee Count22
Asset Turnover0.11
Inventory Turnover194.64
Valuation Ratios
The current PE Ratio of China NT Pharma Group Co., Ltd. is ―. China NT Pharma Group Co., Ltd.’s PEG ratio is -0.07.
PE Ratio―
PS Ratio1.76
PB Ratio-0.17
Price to Fair Value-0.17
Price to FCF-7.24
Price to Operating Cash Flow-17.19
PEG Ratio-0.07
Income Statement
In the last 12 months, China NT Pharma Group Co., Ltd. had revenue of 37.96M and earned -53.36M in profits. Earnings per share was -0.20.
Revenue37.96M
Gross Profit5.26M
Operating Income-13.23M
Pretax Income-53.48M
Net Income-53.36M
EBITDA-8.65M
Earnings Per Share (EPS)-0.20
Cash Flow
In the last 12 months, operating cash flow was -22.56M and capital expenditures -47.00K, giving a free cash flow of -22.61M billion.
Operating Cash Flow-22.56M
Free Cash Flow-22.61M
Free Cash Flow per Share-0.03
Dividends & Yields
China NT Pharma Group Co., Ltd. pays an annual dividend of HK$0.035, resulting in a dividend yield of ―
Dividend Per ShareHK$0.035
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change200.00%
50-Day Moving Average0.83
200-Day Moving Average0.71
Relative Strength Index (RSI)40.19
Average Volume (3m)1.68M
Important Dates
China NT Pharma Group Co., Ltd. upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateAug 8, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
China NT Pharma Group Co., Ltd. as a current ratio of 0.02, with Debt / Equity ratio of -114.39%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap5.61
Net Debt to EBITDA-42.35
Interest Coverage Ratio-0.42
Taxes
In the past 12 months, China NT Pharma Group Co., Ltd. has paid -123.00K in taxes.
Income Tax-123.00K
Effective Tax Rate<0.01
Enterprise Valuation
China NT Pharma Group Co., Ltd. EV to EBITDA ratio is -50.09, with an EV/FCF ratio of -46.87.
EV to Sales11.41
EV to EBITDA-50.09
EV to Free Cash Flow-46.87
EV to Operating Cash Flow-47.79
Balance Sheet
China NT Pharma Group Co., Ltd. has HK$4.63M in cash and marketable securities with HK$316.72M in debt, giving a net cash position of -HK$312.09M billion.
Cash & Marketable SecuritiesHK$4.63M
Total DebtHK$316.72M
Net Cash-HK$312.09M
Net Cash Per Share-HK$0.46
Tangible Book Value Per Share-HK$1.51
Margins
Gross margin is 51.27%, with operating margin of -34.84%, and net profit margin of -140.56%.
Gross Margin51.27%
Operating Margin-34.84%
Pretax Margin-140.89%
Net Profit Margin-140.56%
EBITDA Margin-22.79%
EBIT Margin-34.84%
Analyst Forecast
The average price target for China NT Pharma Group Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―